HIF sustain a transcriptional regulatory circuit of EPAS1 expression in renal clear cell carcinoma

Initiation and sustainment of oncogenic signaling is a hallmark of cancer evolution and progression. In renal clear cell carcinoma, loss of von Hippel-Lindau protein causes stabilization of hypoxia-inducible transcription factors (HIF) evoking a pseudo-hypoxic response, perturbing epithelial homeostasis and leading to cancer development. Although genetic polymorphisms link the EPAS1 oncogene (coding for HIF-2α) to renal cancer and anti-HIF-2 compounds emerge as renal tumor therapies, little is known about transcriptional dysregulation of this factor in renal malignancies. We use genetic, epigenetic and transcriptomic data from large patient cohorts and cell models to dissect mechanisms of augmented EPAS1 transcription in clear cell renal cell carcinoma. We define an oncogenic enhancer of EPAS1 which operates depending on the presence of HIF and renal lineage-specific factors, thereby providing evidence for an auto-regulatory feed-forward circuit of HIF-2α regulation which promotes renal cancer growth.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-02-19
DOI
https://doi.org/10.1038/s41467-026-68576-0
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HIF sustain a transcriptional regulatory circuit of EPAS1 expression in renal clear cell carcinoma

Julia Naas, Andre Kraus, Marc P. Stemmler, Franziska Gsottberger et al.
Nature Communications
Cancer, Hypoxia, and Metabolism
article

HIF sustain a transcriptional regulatory circuit of EPAS1 expression in renal clear cell carcinoma

Julia Naas, Andre Kraus, Marc P. Stemmler, Franziska Gsottberger, Stephanie Naas, Johannes Schödel, René Krüger, Steffen Grampp, Victoria Lauer, Fabian Müller, Mario Schiffer, Bernd Wullich, Arndt Hartmann
article en

Abstract

Initiation and sustainment of oncogenic signaling is a hallmark of cancer evolution and progression. In renal clear cell carcinoma, loss of von Hippel-Lindau protein causes stabilization of hypoxia-inducible transcription factors (HIF) evoking a pseudo-hypoxic response, perturbing epithelial homeostasis and leading to cancer development. Although genetic polymorphisms link the EPAS1 oncogene (coding for HIF-2α) to renal cancer and anti-HIF-2 compounds emerge as renal tumor therapies, little is known about transcriptional dysregulation of this factor in renal malignancies. We use genetic, epigenetic and transcriptomic data from large patient cohorts and cell models to dissect mechanisms of augmented EPAS1 transcription in clear cell renal cell carcinoma. We define an oncogenic enhancer of EPAS1 which operates depending on the presence of HIF and renal lineage-specific factors, thereby providing evidence for an auto-regulatory feed-forward circuit of HIF-2α regulation which promotes renal cancer growth.

Nature CommunicationsVol. 17(1)
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Max Perutz Labs (AT), Universitätsklinikum Erlangen (DE), Comprehensive Cancer Center Erlangen (DE), Medical University of Vienna (AT)
Deutsche Forschungsgemeinschaft, Universität Wien, Medizinische Universität Wien
Openalex Percentile: Top 49%
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.